全球藥物研發外包市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球藥物研發外包市場預計將從2025年的50.2億美元成長至2034年的101.5億美元，2026年至2034年的複合年成長率（CAGR）為8.14%。隨著製藥和生物技術公司越來越依賴外包合作夥伴來加速研發並降低營運成本，該市場正在快速擴張。新療法的需求不斷成長、藥物研發過程日益複雜以及對專業知識的需求，都促使企業與合約研究組織（CRO）建立合作關係。人工智慧、高效能篩檢和數據分析技術的進步也提高了藥物研發活動的效率，從而推動了已開發市場和新興市場的整體成長。

癌症、心血管疾病和神經系統疾病等慢性病發病率的上升正在推動創新藥物研發計畫的投資。製藥公司正在將臨床前測試、標靶識別和臨床試驗支援外包，以提高效率並縮短研發週期。將具有成本效益的藥物推向市場並保持產品線競爭力的壓力日益增大，進一步刺激了對外包服務的需求。此外，政府為支持藥物創新而推出的利多政策也對全球市場擴張產生了正面影響。

隨著技術的不斷進步以及對精準醫療和生物製藥領域的投資不斷增加，該市場的未來前景極其光明。新興市場可望憑藉其較低的營運成本和高素質的科研人才，成為重要的外包中心。雲端研究平台和自動化技術的日益普及可望進一步提升協作效率和資料管理水準。隨著製藥公司持續致力於加快藥物核准和提高研發效率，預計該市場將在全球範圍內實現持續的長期成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含多個關鍵組成部分，旨在幫助您全面了解市場環境。

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局概述。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和貢獻。

競爭格局：本部分詳細評估了主要市場參與企業的市場定位、產品系列、策略舉措和財務表現。它深入分析了競爭動態以及主要參與企業所採取的策略，提供了寶貴的見解。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新的投資機會。本部分重點在於潛在的成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球藥物研發外包市場：依工作流程分類

• 市場分析、洞察與預測
• 目標識別和篩檢
• 目標驗證和功能資訊學
• 先導化合物的篩選與最佳化
• 臨床前開發

第5章：全球藥物研發外包市場：依治療領域分類

• 市場分析、洞察與預測
• 呼吸系統疾病
• 疼痛與麻醉
• 腫瘤疾病
• 眼科疾病
• 血液疾病
• 心血管疾病
• 內分泌疾病
• 消化系統疾病
• 免疫失調
• 抗感染藥物
• 中樞神經系統疾病
• 皮膚病
• 泌尿生殖系統疾病

第6章 全球藥物研發外包市場：依藥物類型分類

• 市場分析、洞察與預測
• 低分子化合物
• 聚合物化合物（生物製劑）

第7章 全球藥物研發外包市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥公司
• 生技公司
• 學術研究機構
• 其他

第8章 全球藥物研發外包市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Charles River Laboratories International Inc
  • Thermo Fisher Scientific Inc
  • WuXi AppTec Co. Ltd
  • Pharmaron Beijing Co. Ltd
  • Evotec SE
  • Curia Global Inc
  • GenScript BIoTech Corporation
  • Laboratory Corporation Of America Holdings
  • Eurofins Scientific SE
  • Merck & Co. Inc

The global drug discovery outsourcing market size is expected to reach USD 10.15 Billion in 2034 from USD 5.02 Billion in 2025, growing at a CAGR of 8.14 during 2026-2034.This market is witnessing rapid expansion as pharmaceutical and biotechnology companies increasingly rely on outsourcing partners to accelerate research and reduce operational costs. Rising demand for novel therapeutics, growing complexity in drug development, and the need for specialized expertise are encouraging companies to collaborate with contract research organizations. Advancements in artificial intelligence, high-throughput screening, and data analytics are also improving efficiency in drug discovery activities, supporting overall market growth across developed and emerging economies.

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is driving investment in innovative drug development programs. Pharmaceutical firms are outsourcing preclinical studies, target identification, and clinical trial support to improve productivity and shorten development timelines. Growing pressure to launch cost-effective medicines and maintain competitive pipelines is further boosting demand for outsourcing services. In addition, favorable government initiatives supporting pharmaceutical innovation are positively influencing market expansion worldwide.

Future prospects for the market remain highly promising due to continuous technological advancements and rising investments in precision medicine and biologics. Emerging economies are expected to become major outsourcing hubs because of lower operational costs and skilled scientific talent. Increasing adoption of cloud-based research platforms and automation technologies will further improve collaboration and data management. As pharmaceutical companies continue focusing on faster drug approvals and research efficiency, the market is expected to witness sustained long-term growth globally.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Workflow

• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Preclinical Development

By Therapeutic Area

• Respiratory System Disorders
• Pain and Anesthesia
• Oncology Disorders
• Ophthalmology Disorders
• Hematology Disorders
• Cardiovascular Disorders
• Endocrine Disorders
• Gastrointestinal Disorders
• Immunomodulation Disorders
• Anti-Infective
• Central Nervous System Disorders
• Dermatology Disorders
• Genitourinary System Disorders

By Drug Type

• Small Molecules
• Large Molecules (Biologics)

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutes
• Others

COMPANIES PROFILED

• Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd., Pharmaron Beijing Co. Ltd., Evotec SE, Curia Global Inc., GenScript Biotech Corporation, Laboratory Corporation of America Holdings, Eurofins Scientific SE, Merck & Co. Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Workflow
• 4.2. Target Identification & Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Target Validation & Functional Informatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Lead Identification & Candidate Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Preclinical Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapeutic Area
• 5.2. Respiratory System Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pain and Anesthesia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Oncology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Ophthalmology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hematology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Endocrine Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Gastrointestinal Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Immunomodulation Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Anti-Infective Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Central Nervous System Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Dermatology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.14. Genitourinary System Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Small Molecules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Large Molecules (Biologics) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Workflow
  • 8.2.2 By Therapeutic Area
  • 8.2.3 By Drug Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Workflow
  • 8.3.2 By Therapeutic Area
  • 8.3.3 By Drug Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Workflow
  • 8.4.2 By Therapeutic Area
  • 8.4.3 By Drug Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Workflow
  • 8.5.2 By Therapeutic Area
  • 8.5.3 By Drug Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Workflow
  • 8.6.2 By Therapeutic Area
  • 8.6.3 By Drug Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL DRUG DISCOVERY OUTSOURCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Charles River Laboratories International Inc
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 WuXi AppTec Co. Ltd
  • 10.2.4 Pharmaron Beijing Co. Ltd
  • 10.2.5 Evotec SE
  • 10.2.6 Curia Global Inc
  • 10.2.7 GenScript Biotech Corporation
  • 10.2.8 Laboratory Corporation Of America Holdings
  • 10.2.9 Eurofins Scientific SE
  • 10.2.10 Merck & Co. Inc